ZYRAYDI Trademark

Trademark Overview


On Friday, March 18, 2022, a trademark application was filed for ZYRAYDI with the United States Patent and Trademark Office. The USPTO has given the ZYRAYDI trademark a serial number of 97319656. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, May 22, 2024. This trademark is owned by Zelira Therapeutics Limited. The ZYRAYDI trademark is filed in the Pharmaceutical Products category with the following description:

Non-prescription medicines, namely, pills, tablets, capsules, caplets, and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological, immune system related diseases and disorders, Parkinson's disease, insomnia, diabetic neuropathy, Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; medical and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurologica...
zyraydi

General Information


Serial Number97319656
Word MarkZYRAYDI
Filing DateFriday, March 18, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, May 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNon-prescription medicines, namely, pills, tablets, capsules, caplets, and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological, immune system related diseases and disorders, Parkinson's disease, insomnia, diabetic neuropathy, Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; medical and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological, immune system related diseases and disorders, Parkinson's disease, insomnia, diabetic neuropathy, Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZelira Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPerth WA6000
AU

Trademark Events


Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION ENTERED
Wednesday, March 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Monday, July 24, 2023ASSIGNED TO EXAMINER
Wednesday, August 2, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 2, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 1, 2023NON-FINAL ACTION WRITTEN
Friday, December 1, 2023NON-FINAL ACTION E-MAILED
Friday, December 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, February 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED